News

The Food and Drug Administration's approval in 2023 of lecanemab—a novel Alzheimer's therapy shown in clinical trials to ...
Only around 74% of the city's kindergarteners have an MMR vaccine, far below the state average and herd immunity for the ...
Teens who are engaged increase their academic skills, engage other teens and contribute positively to the community. That is ...
In a recent study, researchers found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer's disease who received lecanemab infusions.
The Food and Drug Administration's approval in 2023 of lecanemab - a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression - was met with enthusiasm by many in the ...
ALTON - Siteman Cancer Center, Alton Memorial Hospital and Senior Services Plus (SSP) are once again hosting a Bingo Lunch ...
EDWARDSVILLE/EAST ST. LOUIS - Metro East residents received valuable information, participated in health screenings, enjoyed ...
The study has been published ahead of print in the prestigious journal ‘Diabetes’, published by the American Diabetes ...
Which Missouri high school athlete had the best week? Each week, SBLive scours the state for the top spring sports performers ...
Shannon Lenze, an associate professor of psychiatry at WashU Medicine, has received the William H. Danforth St. Louis ...
In a breakthrough, Indian and US researchers have jointly announced the discovery of a new subtype of Maturity-Onset Diabetes ...
The shelter remains closed as it works to contain the spread, and the shelter's veterinary team reports no new cases of parvo ...